UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 1-16789
INVERNESS MEDICAL INNOVATIONS, INC.
NYSE ALTERNEXT US LLC (formerly the American Stock Exchange LLC)
(Exact name of Issuer as specified in its charter, and name of Exchange where security is
listed and/or registered)
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453
(781) 647-3900
(Address, including zip code, and telephone number, including area code, of Issuers principal executive offices)
Series B Convertible Perpetual Preferred Stock, par value $0.001 per share
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of
securities from listing and registration:
o 17 CFR 240.12d2-2(a)(1)
o 17 CFR 240.12d2-2(a)(2)
o 17 CFR 240.12d2-2(a)(3)
o 17 CFR 240.12d2-2(a)(4)
o Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the
class of securities from listing and/or withdraw registration on the Exchange.
þ Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange
and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of
securities from listing and registration on the Exchange.
Pursuant to the requirements of the Securities Exchange Act of 1934, Inverness Medical Innovations,
Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for
filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned
duly authorized person.
|
|
|
|
|
|
|
January 2, 2009
|
|
By:
|
|
/s/ David Teitel
|
|
Chief Financial Officer |
|
|
|
|
|
|
|
Date
|
|
|
|
Name
|
|
Title |
This voluntary delisting is a result of Inverness Medical Innovations, Inc. pending move to the New
York Stock Exchange (NYSE). Inverness Medical Innovations, Inc.s first day of trading on the
NYSE will be on or about January 6, 2009.